An aquatic phage, designated F20, was characterized and its physico-chemical characteristics studied. F20 was specifically virulent to only two strains of Enterobacter aerogenes (ATCC 13048 and the multi-drug-resistant strain K113) among other species tested (n515). It was classified in the family Siphoviridae of T1-like viruses and contained a linear dsDNA genome estimated to be 51.5 kbp enclosed by an isometric capsid of 50±2 nm in diameter and a tail of 150±3 nm in length. F20 was able to survive in a broad pH range between 4 and 11, showed potential for future animal trials using oral solution and resisted chloroform and ethanol. It exhibited remarkable stability between room temperature and 70 6C for up to 150 min, and even up to 6 months at room temperature. Knowledge of this phage belonging to the widespread T1-like viruses might be helpful for adopting therapeutic strategies against E. aerogenes.
More than a decade before the official finding of the first antibiotic named penicillin, the bacteriophages (phages) were discovered (reviewed by Duckworth, 1976) . Edward Twort in 1915 reported a filterable entity capable of destroying bacterial cultures, forming a clear spot (plaque) on bacterial lawns. Later, Felix d'Herelle in 1917 also observed the same phenomenon and named this entity bacteriophage, meaning the bacteria eater (Adams, 1969; Sulakvelidze et al., 2001) . Bacteriophages are characterized by their ability to selectively infect a bacterial host belonging to a single strain of a genus or species. Since the preantibiotic era, the use of virulent phages to combat bacterial infections has been suggested for diseases such as cholera, diphtheria, bubonic plague and anthrax (Summers, 2001) . It has been reported that phages are potentially a very valuable tool for dealing with infections caused by bacterial pathogens and in some cases of antibiotic resistance, phage therapeutics might be the only effective modality currently available. Unlike the required repeated doses of antibiotics, a single dose of phage not only reaches the site of infection but also multiplies within the pathogen and specifically destroys it. In addition, phages are unable to multiply in eukaryotic cells or incorporate their genomes into eukaryotic cell DNA; therefore, no phage-mediated harmful effects to eukaryotic cells have been reported, to our knowledge. Moreover, the United States Food and Drug Administration has approved the use of phages as an alternative to antibiotics, such as the inclusion of Listeria phage in foods (USFDA, 2006) , which has re-established confidence in the use of phages as antimicrobial agents.
Enterobacter spp., the third leading cause of respiratory tract, nosocomial and hospital-acquired bloodstream infections, are Gram-negative infectious bacterial human pathogens (CDC, 1999; Piagnerelli et al., 2000) . The two most common Enterobacter spp. causing human infections are E. aerogenes and E. cloacae, responsible for 90-99 % of Enterobacter infections. These two species have been included together in almost all clinical studies of Enterobacter infections (Marcos et al., 2008) . These pathogens exhibit high resistance to commonly used antibiotics, including vancomycin, and have become a serious global clinical problem and are usually predominant in hospitals causing complicated secondary infections (Bornet et al., 2000) . Vancomycinresistant enterococci (VRE) were first detected outside hospital environments in 1993 and have become increasingly important pathogens that infect humans, not only because of their antibiotic resistance but also because of their clinical implications (Alekshun & Levy, 2007; Wright, 2007) . In order to overcome the emerging bacterial resistance problems, research has been targeted at the discovery of novel anti-enterobacterial and anti-VRE agents, but a role for Enterobacter phages needs further attention.
Lytic phage research has generally advanced after the discovery of T-series phages; however, efforts to discover E. aerogenes phages have not progressed as rapidly even though pathogenic E. aerogenes infections are a significant human health problem. Here, we describe Enterobacter phage F20 that was successfully isolated from an aquatic source and infects E. aerogenes ATCC 13048, using the method described by Lu et al. (2003) . The phage F20 was successfully purified from a lawn of host bacteria that had been lysed. Purified phage produced large, clear, round plaques of 2-3 mm in diameter on a lawn of E. aerogenes ATCC 13048 (Fig. 1a) . Multiplication parameters of phage F20 were determined under one-step growth curve conditions (Fig. S1a , available in JGV Online). A latent period of 35 min and burst time of 90 min, with a highest burst size of 72 p.f.u. (per infection centre), were observed. Besides the host strain E. aerogenes ATCC 13048, F20 was also able to infect a multiple-drug-resistant (MDR) (including vancomycin) strain of E. aerogenes called K113.
The morphology of the F20 phage, determined using a concentrated sample (Yamamoto et al., 1970) , under a transmission electron microscope after negative staining (Lu et al., 2003) was similar to the T1 phage of the family Siphoviridae. Enterobacteria phage T1, one of the original T-series phages, is not related to any of the other T-series phages and remains the least studied of that group. The T1 virion was reported to contain a linear dsDNA genome and have an isometric head 55-60 nm in diameter and a tail 150 nm in length and 7 nm in diameter (Roberts, 2001 ). Similar to T1, phage F20 has a linear dsDNA genome (Fig. S2a, b) enclosed by an isometric head of 50 nm in diameter and a tail of 150 nm in length and 10 nm wide, as shown in Fig. 1(b) . The phage F20 genome was extracted from the concentrated sample after step-gradient (polyethylene glycol 8000 and CsCl) centrifugation (Durmaz & Klaenhammer, 2000) and its nucleotide sequence was determined at the sequencing centre of Seoul National University, Seoul, Republic of Korea. The genome sequence of phage F20 was found to be 51.5 kbp (GenBank accession no. JN672684), close to the size of the T1 phage genome (48.5 kbp). Genomes of the phages closely related to phage F20 were fetched from GenBank and the taxonomic position of F20 was confirmed by inferring the evolutionary history (Tamura et al., 2007) by using the maximum-parsimony method bootstrap test (1000 replicates) of close-neighbourinterchange algorithm with calculated branch lengths (Fig.  1c) . In silico restriction analysis (Roberts et al., 2005) of the F20 genome revealed that most of the restriction sites for StuI, NcoI, EcoRI, XhoI and HindIII were common in both F20 and T1, whereas sites for ApaI, AvaI, BamHI, BstEII, KpnI and XbaI were found to be absent in F20 and T1. Gel electrophoretic analysis of possible structural proteins, in combination with electron microscopy, is considered a useful tool for phage differentiation (Lin et al., 2010) , as the pattern of major protein bands differs in different families of phage. The structural proteins of phage F20 were analysed (Lu et al., 2003) by SDS-PAGE using a purified phage sample, and eight major proteins with molecular masses estimated at 23, 27, 32, 35, 40, 50, 55 and 65 kDa (Fig. S2c ) were detected. Another described Enterobacter phage shows six major protein bands with different molecular masses (Lin et al., 2010) . This phage is also classified in the family Siphoviridae. The structural and genomic features of phage F20 are consistent with T1. Hence, F20 might be classified as a T1-like phage belonging to the family Siphoviridae, according to the International Committee on Taxonomy of Viruses (Fauquet et al., 2005) .
E. aerogenes is one of the bacteria resistant to multiple antibiotics which are normally used for the treatment of infections caused by enterococci, such as vancomycin and ampicillin (SCIC, 1999 ). This species is also able to cause various community-acquired infections such as urinary tract infections. In order to target this pathogen, the host specificities of the phage F20 were investigated. It was observed that F20 was specifically virulent to two related strains of E. aerogenes, ATCC 13048 and the clinical strain K113 that is resistant to vancomycin, ampicillin and cefazolin. F20 was found to be specific for E. aerogenes and did not infect the other species of bacteria tested (n515), such as Acinetobacter baumannii, Bacillus subtilis and Bacillus cereus, Escherichia coli, Listeria monocytogenes, Pseudomonas aeruginosa, Salmonella enteritidis and Salmonella typhimurium, and Staphylococcus aureus ( Table 1) . As F20 is categorized in the family Siphoviridae, we have compared its host range results with other reported phages from the same family. Like F20, three phages (WS-EP20, WS-EP26 and WS-EP28) were also reported to specifically infect Enterobacter species (Loessner et al., 1993) . Similarly, enterobacteria phages were found to infect different strains of E. coli (Jamalludeen et al., 2007) . Phage F20 was found active against host cells at an m.o.i. of 0.1; similar m.o.i. values for activity against specific hosts were reported for phage UZ1 against E. aerogenes (Verthe et al., 2004) and for other isolated phages of the family Siphoviridae (Lin et al., 2010) . Taken together, these findings indicate the host specificity of phage F20.
Stability studies of phage F20 were conducted using different pH, chemicals, temperatures and time, using a temperature-controlled incubator or water baths, as described in supplementary methods, and the results are summarized in Fig. S1 . The phage was stable over a broad range of pH from 4 to 11. There was a significant reduction in the phage titre below pH 4, which was further decreased up to pH 1. Similar results were observed when the phage was treated at pH 12. Importantly, it was noticed that the phage titre was not decreased by more than 2.5 log 10 units at any pH level, whether it was extremely acidic (pH,4) or basic (pH 12). The phage was resistant to chloroform and ethanol at high concentrations (10 %, v/v), whereas it was not stable in the same concentration of other chemicals tested such as hydrogen peroxide, phenol, butanol, ethyl acetate and hexane. However, phage F20 was resistant to treatment with 1 % (v/v) phenol or hydrogen peroxide (Fig. S1c) . Unlike the common phenomenon of chloroform and ethanol resistance by phages (Lin et al., 2010; Wang et al., 2010) , survival in a broad pH range is rarely reported for the Enterobacter phages (Verthe et al., 2004) .
The thermal stability of phage F20 was determined at different temperatures from 25 to 70 uC. Phage F20 was found to be stable up to 70 u C for 150 min with only a slight reduction in titre (,0.2 log 10 units p.f.u. ml
21
). These findings indicated the high thermal tolerability of phage F20 (Fig. S3a) . Comparatively, thermostable phages from the family Siphoviridae were reported to be stable at 60 u C but their titres were dramatically decreased by 50 % at 70 u C (Lin et al., 2010; Lu et al., 2003) . F20 was also investigated for its long-term stability at temperatures from 220 to 37 u C with or without stabilizers such as glycerol, glycine and skimmed milk. No significant loss in the phage titre was observed after 6 months at temperatures below 4 u C (Fig. 2a, b) . Good stability was observed at 25 u C over 6 months with or without stabilizers, with only a slight decrease in titre (Fig. 2c) . On the other hand, F20 was stable for only 1 month at 36 uC and its titre drastically decreased at 6 months (Fig. 2d) . In addition, three stabilizers (glycerol, glycine and skimmed milk) were found to be suitable for long-term stability of the phage F20. When F20 was exposed to ultraviolet radiation (UV) at 254 nm, a sudden drop in the phage titre was observed within 10 s. This drop further decreased by more than 95 % in the next 20 s. Notably, all phage particles were eradicated within 40 s of exposure (Fig. S3b) .
The stability tests on phage F20 at different pH and temperatures, as well as chemicals and UV radiation, were performed for the potential practical application in future animal trials using F20 in oral solution. In delivering phages orally, the pH encountered in the gut could be a critical barrier because a low pH level can affect phage stability. The different sensitivities to chemicals and UV radiation could be applied to prevent bacterial contamination during the preparation of phage F20 stock and to prevent phage contamination of the laboratory environment, respectively. Thermal and long-term stabilities are the primary requirement for any possible commercial use of the phage as they can reduce the cost of storage significantly.
The growing resistance of bacterial pathogens, including E. aerogenes, to the presently used antibiotics has extended throughout the world. Novel strategies to control E. aerogenes are needed to keep pace with pathogens, and hence our approach was taken to uncover the new bacterial virus against E. aerogenes. Together with the observations described above, to the best of our knowledge, this is the first report of a T1-like phage virulent to E. aerogenes with 
